标题
Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
作者
关键词
-
出版物
PROSTAGLANDINS & OTHER LIPID MEDIATORS
Volume -, Issue -, Pages 106762
出版商
Elsevier BV
发表日期
2023-06-23
DOI
10.1016/j.prostaglandins.2023.106762
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration
- (2023) Charles N. Serhan et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation
- (2022) Denise Biagini et al. FREE RADICAL BIOLOGY AND MEDICINE
- Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response
- (2022) James Turnbull et al. JOURNAL OF INFECTIOUS DISEASES
- Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions
- (2022) Simon C. Dyall et al. PROGRESS IN LIPID RESEARCH
- The immunology and immunopathology of COVID-19
- (2022) Miriam Merad et al. SCIENCE
- Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
- (2022) Vivian Vasconcelos Costa et al. eLife
- MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis
- (2022) Kimberly Pistorius et al. EBioMedicine
- Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection
- (2022) Luciana P. Tavares et al. mBio
- Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation
- (2022) Mauro Perretti et al. Annual Review of Pharmacology and Toxicology
- Cysteinyl-maresin 3 inhibits IL-13 induced airway hyperresponsiveness through alternative activation of the CysLT1 receptor
- (2022) Jesper Säfholm et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19?
- (2022) David H. Dockrell et al. EUROPEAN RESPIRATORY JOURNAL
- Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease
- (2022) Antonio Recchiuti et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation
- (2021) Nan Chiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
- (2021) Antonio Recchiuti et al. FASEB JOURNAL
- Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19
- (2021) Duco Steven Koenis et al. CIRCULATION RESEARCH
- High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients
- (2021) Anne‐Sophie Archambault et al. FASEB JOURNAL
- Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
- (2021) Francesco Palmas et al. PLoS One
- Protectins PCTR1 and PD1 Reduce Viral Load and Lung Inflammation During Respiratory Syncytial Virus Infection in Mice
- (2021) Katherine H. Walker et al. Frontiers in Immunology
- Resolvin T-series Reduce Neutrophil Extracellular Traps
- (2021) Nan Chiang et al. BLOOD
- Concurrent Control of KSHV Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: A New Prospect to the Therapeutic Potential of Lipoxin A4
- (2020) Kumari Asha et al. JOURNAL OF VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
- (2020) Dipak Panigrahy et al. CANCER AND METASTASIS REVIEWS
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Viroporins and inflammasomes: A key to understand virus-induced inflammation
- (2020) N.S. Farag et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
- (2020) Wen Wen et al. Cell Discovery
- Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19
- (2020) Evangelos Andreakos et al. ALLERGY
- Specialized pro-resolving mediator network: an update on production and actions
- (2020) Nan Chiang et al. Essays in Biochemistry
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
- (2020) Benjamin Schwarz et al. JOURNAL OF IMMUNOLOGY
- Resolvin D4 attenuates the severity of pathological thrombosis in mice
- (2019) Deya Cherpokova et al. BLOOD
- Concise Review: Pro‐Resolving Lipid Mediators and Receptors in Stem Cell Biology
- (2019) Mario Romano et al. Stem Cells Translational Medicine
- Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes
- (2019) Bruce D. Levy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-β–STAT3-dependent pathway
- (2018) Patrick B. Ampomah et al. FASEB JOURNAL
- Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation
- (2018) Katerina Pyrillou et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression
- (2018) Nina Kim et al. JOURNAL OF IMMUNOLOGY
- Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
- (2017) Charles N. Serhan FASEB JOURNAL
- Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology
- (2017) Naveen K. Rajasagi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection
- (2017) M Codagnone et al. Mucosal Immunology
- Kaposi sarcoma herpesvirus-associated cancers and related diseases
- (2017) Priscila H. Goncalves et al. Current Opinion in HIV and AIDS
- Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis
- (2016) S Arora et al. CELL DEATH AND DIFFERENTIATION
- Novel Resolvin D2 Receptor Axis in Infectious Inflammation
- (2016) Nan Chiang et al. JOURNAL OF IMMUNOLOGY
- Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection
- (2015) Yumiko Imai BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways
- (2015) Jesmond Dalli et al. FASEB JOURNAL
- Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells
- (2015) Alexandru Marginean et al. Translational Research
- The Specialized Proresolving Mediator 17-HDHA Enhances the Antibody-Mediated Immune Response against Influenza Virus: A New Class of Adjuvant?
- (2014) Sesquile Ramon et al. JOURNAL OF IMMUNOLOGY
- Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection
- (2014) J. Dalli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
- (2013) Masayuki Morita et al. CELL
- Resolution of inflammation: an integrated view
- (2013) Almudena Ortega-Gómez et al. EMBO Molecular Medicine
- The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype
- (2013) Jesmond Dalli et al. FASEB JOURNAL
- Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology
- (2013) K A Shirey et al. Mucosal Immunology
- Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
- (2012) C. Gudiol et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inflammation 2010: New Adventures of an Old Flame
- (2010) Ruslan Medzhitov CELL
- Controlling Herpes Simplex Virus-Induced Ocular Inflammatory Lesions with the Lipid-Derived Mediator Resolvin E1
- (2010) N. K. Rajasagi et al. JOURNAL OF IMMUNOLOGY
- Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection
- (2010) C. Cilloniz et al. JOURNAL OF VIROLOGY
- Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
- (2010) Deepali Kumar et al. LANCET INFECTIOUS DISEASES
- Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4- and IFN-β-dependent
- (2010) K A Shirey et al. Mucosal Immunology
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started